Chemistry of radioiodine

Species transformation and removal mechanism of various iodine species at the Bi2O3@MnO2 interface

Long-term exposure to excessive iodine via drinking water significantly increases the risk of thyroid diseases. Further, the mechanisms and feasible technologies for iodine removal are far from being well elucidated. In this study, we constructed a heterogeneous Bi₂O₃@MnO₂ interface with oxidation and adsorption efficiency toward iodide (I^-), and investigated the performance and mechanisms involved in iodine removal. Bi₂O₃@MnO₂ at the optimized Bi/Mn ratio of 0.05:1 had a maximum adsorption capacity of 1.19, 1.21, and 1.06 mg/g toward I^-, iodine elemental (I₂), and iodate (IO₃^-), respectively. According to the density functional theory (DFT) calculation, Bi₂O₃@MnO₂ had an adsorption energy of -2.34, -2.11, and -3.89 eV for I^-, I₂, and IO₃^-, and exhibited a better band structure and state density character for iodine removal. Based on the results of XPS, HPLC, and LC-ICP-MS characterization, Bi₂O₃ plays an important role in adsorbing and capturing I^- whereas MnO₂ dominates the moderate oxidation of I^- and the adsorption of I^- and I₂. The adsorbed I^- and I₂ concentrations on the Bi₂O₃@MnO₂ surfaces were 146.3 μg/L and 18.3 μg/L. Notably, IO₃^- was not detected owing to its moderate oxidation effect. The coexisting ions of chloride (Cl^-) and bromide (Br^-) tended to occupy the Bi₂O₃ lattice and form insoluble BiOCl and BiOBr. Further, reductive species, such as sulphite (SO₃^2-), may reduce MnO₂ to Mn(III) and Mn(II). The synergistic effect between moderate oxidation and adsorption led to Bi₂O₃@MnO₂ with high iodine removal capability. Overall, this study proposes a strategy for designing suitable interfaces and adsorbents for iodine removal; however, further studies are necessary to advance its application in practice.

Synchronous Moderate Oxidation and Adsorption on the Surface of γ-MnO2 for Efficient Iodide Removal from Water

Long-term exposure to excessive iodine via drinking water presents health risks. Moderate oxidation of iodide (I^-) to iodine (I₂) has a better iodine removal effect than excessive oxidation to iodate (IO₃^-). This study combines computational and experimental methods to construct a heterogeneous interface with synchronous I^- moderate oxidation and I₂ adsorption to increase the total iodine removal. Compared to other forms of crystal manganese dioxide (MnO₂), theoretical calculations predict that MnO₂ with a γ-crystal structure has the lowest adsorption energy, that is, -1.20 eV, and a slight overlap between the conduction and valence bands, which favors electron transfer between I^- and Mn(IV) and I₂ adsorption. Thus, γ-type MnO₂ was designed by adjusting the precursor Mn sources and hydrothermal reaction conditions. The liquid chromatography-inductively coupled plasma-mass spectrometry and high-performance liquid chromatography confirmed that the total iodine concentration in water decreased from 173.7 to 36.3 μg/L after 2 h, with 200 mg/L γ-MnO₂ dosage lower than the national standard of 0.1 mg/L. A minute proportion of I^- in water was converted to IO₃^- (approximately 1.1 μg/L). The current I^- adsorbent performed better than previously reported ones. During iodine removal, most of the I^- migrated from water to the surface of γ-MnO₂, and the ratio of I^- to I₂ was determined to be 1:0.6 by X-ray photoelectron spectroscopy. This study evaluates iodine species transformation and an optimum strategy for heterogeneous interface design; it is promising for treating high-iodine groundwater.

Radioiodination and biological evaluation of Cimetidine as a new highly selective radiotracer for peptic ulcer disorder detection

One of the most famous techniques for stomach ulcer imaging is the nuclear imaging technique. We aim to focus on the synthesis of 125I-cimetidine (125I-cim) as an agent for peptic ulcer imaging. Cimetidine was labeled with Iodine-125 using a different oxidizing agent (Ch-T, NBS). All factors affecting the labeling yield were optimized. The radiochemical yield of 125I-cim was 98 ± 0.22% at optimum conditions. In vitro stability, in vivo biodistribution of 125I-cimetidine was studied in three groups: control group, pretreated group, and ulcer bearing group. In vivo biodistribution studies of 125I-cim revealed high uptake in the stomach ulcer, reaching about 75.4 ± 1.2% ID/g at 15 min post-injection, than pretreated groups compared to the control. The results showed the suitability of using 125I-cimetidine for stomach ulcer imaging.

Guest-host complexes of 1-iodochlordecone and β-1-iodo-pentachlorocyclohexane with cyclodextrins as radiotracers of organochlorine pesticides in polluted water

The chlordecone (CLD) and the β-hexachlorocyclohexane (β-HCH) are persistent organic pollutants with a great environmental stability that cause severe affectations to health. The concentration of these pesticides in the environment is low, which represent a problem for their determination, even for the modern analytical methods. The labeling of these compounds with an iodine radioisotope for their use as radiotracers is a potential solution to this problem. The present work studies the interaction of 1-iodochlordecone (I-CLD) and β-1-iodo-pentachlorocyclohexane (I-β-HCH) with cyclodextrins (CDs), during the formation of molecular inclusion complexes pesticide@CDs. The methodology of multiple minima hypersurfaces, quantic calculations based on density functional theory and a topologic study of electronic density were used to corroborate the stability of I-CLD@CDs and I-β-HCH@CDs complexes. Three main types of guest-host complexes in relation to the occlusion grade were observed: with total occlusion, with partial occlusion and external interaction without occlusion. The more stable complexes are obtained when the γ-CD is the host molecule. The formed complexes with radiolabelled pollutants are analogous with the ones reported in previous works. These results confirm the utility of these complexes for the removal of organochlorine pesticides from polluted water and, also, demonstrate the possibility of using the I-CLD and the I-β-HCH as possible radiotracers for these pollutants in further studies with environmental proposes.

Cross-Isotopic Bioorthogonal Tools as Molecular Twins for Radiotheranostic Applications

Radiotheranostics are designed by labeling targeting (bio)molecules with radionuclides for diagnostic or therapeutic application. Because the pharmacokinetics of therapeutic compounds play a pivotal role, chemically closely related imaging agents are used to evaluate the overall feasibility of the therapeutic approach. "Theranostic relatives" that utilize different elements are frequently used in clinical practice. However, variations in pharmacokinetics, biodistribution, and target affinity due to different chemical properties of the radioisotopes remain as hurdles to the design of optimized clinical tools. Herein, the design and synthesis of structurally identical compounds, either for diagnostic (18 F and a stable metal isotope) or therapeutic application (radiometal and stable 19 F), are reported. Such "molecular twins" have been prepared by applying a modular strategy based on click chemistry that enables efficient radiolabeling of compounds containing a metal complex and a tetrazine moiety. This additional bioorthogonal functionality can be used for subsequent radiolabeling of (bio)molecules or pretargeting approaches, which is demonstrated in vitro.

Chemical and thermodynamic characteristics of the isotopic exchange reaction between radioiodine and iodohippuric acid isomers

The parameters affecting the absolute radiochemical yield of the isotopic exchange reaction between radioiodine (125I-) and iodohippuric acid isomers on molten ammonium acetate as a medium exchange at 120 degrees C without any carrier added (radioiodine, 125I-) was determined. The isotopic exchange reactions of radioiodine as 125I- for iodine-127 of o- and p-iodohippuric acid isomers occur more rapidly than m-iodohippuric acid isomer. These reactions proceed by nucleophilic second order substitution reaction. The kinetics and thermodynamic parameters of these isotopic exchange reactions were determined. The absolute radiochemical yield and radio pharmaceutical purity were determined by HPLC and TLC techniques.

The current status of targeted radiotherapy in clinical practice

Biologically targeted radiotherapy in clinical practice requires a molecule which has a relative specificity for tumour tissue--the missile--coupled to a radionuclide with appropriate physical characteristics--the warhead. When administered to a patient this combination should result in selective irradiation of the target tumour cells with relative sparing of normal tissues. Simple ions and small molecules which follow physiological pathways as either the natural substrates or analogues form the best examples of biological targeting. Clinically valuable results are seen with, for instance, iodine uptake by normal and malignant thyroid cells, incorporation of the calci-mimetic element strontium in areas of increased bone metabolism and accumulation of the catecholamine analogue meta-iodobenzylguanidine in neuroblastoma. The use of monoclonal antibodies as targeting vehicles has not proved to be a panacea, yet some patients with lymphoma, hepatoma and ovarian carcinoma have obtained benefit. Current clinical studies in targeted radiotherapy focus on the integration of radionuclide treatment with conventional treatments, and the optimization of such combined approaches. The development of modifications to offset the limitations inherent in the use of crude antibodies also offers an opportunity for improved clinical outcomes.